

 



<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
  "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml"
      xmlns:foaf="http://xmlns.com/foaf/0.1/"
      xmlns:dc="http://purl.org/dc/terms/"
      xmlns:doi="http://dx.doi.org/"
      xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
      xmlns:xsd="http://www.w3.org/2001/XMLSchema-datatypes#"
      lang="en" xml:lang="en"
      itemscope itemtype="http://schema.org/Article"
      class="no-js">
<head prefix="og: http://ogp.me/ns#">
  <title>PLOS ONE: Hyperhomocysteinemia and Mortality after Coronary Artery Bypass Grafting</title>


<link rel="stylesheet" type="text/css"  href="/css/global-min.css?v=izteQ6tu7kgsJZW_xmrYizvKiHM" />


    <!--[if lte IE 7]>
<link rel="stylesheet" type="text/css"  href="/css/lte_ie7-min.css?v=3bykQUyQmReeuobVyPozcJ9LxRc" />
    <![endif]-->


<link rel="stylesheet" type="text/css"  href="/css/jquery-ui-min.css?v=eXDHTEJM0lIAmDe5k0I0Ad4nxNo" />


<link rel="stylesheet" type="text/css"  href="/css/journal.css?v=T7ZVxJfgk9jNxLAJ2qHz1vZpgYU" />


<link rel="stylesheet" type="text/css" media="print" href="/css/print-min.css?v=T5lb0B3q6EXBsuDluc5V5w+AkRc" />


  <link rel="stylesheet" href="http://f.fontdeck.com/s/css/js/www.plosone.org/24557.css" type="text/css"/>

  <!--chartbeat -->
  <script type="text/javascript">var _sf_startpt = (new Date()).getTime()</script>
  <script>document.documentElement.className += ' js';</script>

  <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
  <meta http-equiv="X-UA-Compatible" content="IE=EmulateIE7; IE=EmulateIE9"/>
  <meta name="description" content="PLOS ONE: an inclusive, peer-reviewed, open-access resource from the PUBLIC LIBRARY OF SCIENCE. Reports of well-performed scientific studies from all disciplines freely available to the whole world."/>
  <meta name="keywords" content="PLOS, Public Library of Science, Open Access, Open-Access, Science, Medicine, Biology, Research, Peer-review, Inclusive, Interdisciplinary, Ante-disciplinary, Physics, Chemistry, Engineering"/>
  <meta name="almHost" content="http://alm.plos.org/api/v3/articles"/>
  <meta name="searchHost" content="http://api.plos.org/search" />
  <meta name="termsHost" content="http://api.plos.org/terms" />
  <meta name="solrApiKey" content="plos"/>
  <meta name="almAPIKey" content="3pezRBRXdyzYW6ztfwft" />
  <meta name="currentJournal" content="PLoSONE" />
  <meta name="almRequestBatchSize" content="" />

  <meta name="citation_publisher" content="Public Library of Science"/>
  <meta name="citation_doi" content="10.1371/journal.pone.0000083"/>
  <meta name="dc.identifier" content="10.1371/journal.pone.0000083" />

    <meta name="citation_title" content="Hyperhomocysteinemia and Mortality after Coronary Artery Bypass Grafting"/>
    <meta itemprop="name" content="Hyperhomocysteinemia and Mortality after Coronary Artery Bypass Grafting"/>

      <meta name="citation_author" content="Domenico Girelli"/>
            <meta name="citation_author_institution" content="Department of Clinical and Experimental Medicine, University of Verona, Verona, Italy"/>
      <meta name="citation_author" content="Nicola Martinelli"/>
            <meta name="citation_author_institution" content="Department of Clinical and Experimental Medicine, University of Verona, Verona, Italy"/>
      <meta name="citation_author" content="Oliviero Olivieri"/>
            <meta name="citation_author_institution" content="Department of Clinical and Experimental Medicine, University of Verona, Verona, Italy"/>
      <meta name="citation_author" content="Francesca Pizzolo"/>
            <meta name="citation_author_institution" content="Department of Clinical and Experimental Medicine, University of Verona, Verona, Italy"/>
      <meta name="citation_author" content="Simonetta Friso"/>
            <meta name="citation_author_institution" content="Department of Clinical and Experimental Medicine, University of Verona, Verona, Italy"/>
      <meta name="citation_author" content="Giovanni Faccini"/>
            <meta name="citation_author_institution" content="Institutes of Clinical Chemistry, University of Verona, Verona, Italy"/>
      <meta name="citation_author" content="Claudia Bozzini"/>
            <meta name="citation_author_institution" content="Department of Clinical and Experimental Medicine, University of Verona, Verona, Italy"/>
      <meta name="citation_author" content="Ilaria Tenuti"/>
            <meta name="citation_author_institution" content="Department of Clinical and Experimental Medicine, University of Verona, Verona, Italy"/>
      <meta name="citation_author" content="Valentina Lotto"/>
            <meta name="citation_author_institution" content="Department of Clinical and Experimental Medicine, University of Verona, Verona, Italy"/>
      <meta name="citation_author" content="Giuliano Villa"/>
            <meta name="citation_author_institution" content="Department of Clinical and Experimental Medicine, University of Verona, Verona, Italy"/>
      <meta name="citation_author" content="Patrizia Guarini"/>
            <meta name="citation_author_institution" content="Department of Clinical and Experimental Medicine, University of Verona, Verona, Italy"/>
      <meta name="citation_author" content="Elisabetta Trabetti"/>
            <meta name="citation_author_institution" content="Section of Biology and Genetics, University of Verona, Verona, Italy"/>
      <meta name="citation_author" content="Pier Franco Pignatti"/>
            <meta name="citation_author_institution" content="Section of Biology and Genetics, University of Verona, Verona, Italy"/>
      <meta name="citation_author" content="Alessandro Mazzucco"/>
            <meta name="citation_author_institution" content="Cardiovascular Surgery, University of Verona, Verona, Italy"/>
      <meta name="citation_author" content="Roberto Corrocher"/>
            <meta name="citation_author_institution" content="Department of Clinical and Experimental Medicine, University of Verona, Verona, Italy"/>

    <meta name="citation_date" content="2006/12/20"/>

  <meta name="citation_pdf_url" content="http://dx.plos.org/10.1371/journal.pone.0000083.pdf" />

      <meta name="citation_journal_title" content="PLOS ONE" />
    <meta name="citation_firstpage" content="e83"/>
    <meta name="citation_issue" content="1"/>
    <meta name="citation_volume" content="1"/>
    <meta name="citation_issn" content="1932-6203"/>

    <meta name="citation_journal_abbrev" content="PLoS ONE" />

      <meta name="citation_reference" content="citation_title=Homocysteine and cardiovascular disease.; citation_author=H Refsum; citation_author=PM Ueland; citation_author=O Nygard; citation_author=SE Vollset; citation_journal_title=Annu Rev Med; citation_volume=49; citation_number=1; citation_pages=31-62; citation_date=1998; " />
      <meta name="citation_reference" content="citation_title=Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis.; citation_author=KS McCully; citation_journal_title=Am J Pathol; citation_volume=56; citation_number=2; citation_pages=111-28; citation_date=1969; " />
      <meta name="citation_reference" content="citation_title=Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis.; citation_journal_title=JAMA; citation_volume=288; citation_number=3; citation_pages=2015-22; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=Homocysteine and atherothrombosis.; citation_author=GN Welch; citation_author=J Loscalzo; citation_journal_title=N Engl J Med; citation_volume=338; citation_number=4; citation_pages=1042-50; citation_date=1998; " />
      <meta name="citation_reference" content="citation_title=MTHFR 677C→T polymorphism and risk of coronary heart disease: a meta-analysis.; citation_author=M Klerk; citation_author=P Verhoef; citation_author=R Clarke; citation_author=HJ Blom; citation_author=FJ Kok; citation_journal_title=JAMA; citation_volume=288; citation_number=5; citation_pages=2023-31; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=Meta-analysis of MTHFR 677C→T polymorphism and coronary heart disease: does totality of evidence support causal role for homocysteine and preventive potential of folate?; citation_author=SJ Lewis; citation_author=S Ebrahim; citation_author=G Davey Smith; citation_journal_title=BMJ; citation_volume=331; citation_number=6; citation_pages=1053-8; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Folate therapy and in-stent restenosis after coronary stenting.; citation_author=H Lange; citation_author=H Suryapranata; citation_author=G De Luca; citation_author=C Borner; citation_author=J Dille; citation_journal_title=N Engl J Med; citation_volume=350; citation_number=7; citation_pages=2673-81; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial.; citation_author=JF Toole; citation_author=MR Malinow; citation_author=LE Chambless; citation_author=JD Spence; citation_author=LC Pettigrew; citation_journal_title=JAMA; citation_volume=291; citation_number=8; citation_pages=565-75; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Homocysteine lowering and cardiovascular events after acute myocardial infarction.; citation_author=KH Bonaa; citation_author=I Njolstad; citation_author=PM Ueland; citation_author=H Schirmer; citation_author=A Tverdal; citation_journal_title=N Engl J Med; citation_volume=354; citation_number=9; citation_pages=1578-88; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Homocysteine lowering with folic acid and B vitamins in vascular disease.; citation_author=E Lonn; citation_author=S Yusuf; citation_author=MJ Arnold; citation_author=P Sheridan; citation_author=J Pogue; citation_journal_title=N Engl J Med; citation_volume=354; citation_number=10; citation_pages=1567-77; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies.; citation_author=ES Ford; citation_author=SJ Smith; citation_author=DF Stroup; citation_author=KK Steinberg; citation_author=PW Mueller; citation_journal_title=Int J Epidemiol; citation_volume=31; citation_number=11; citation_pages=59-70; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=Methods of coronary revascularization. Things may not be as they seem.; citation_author=BJ Gersh; citation_author=RL Frye; citation_journal_title=N Engl J Med; citation_volume=352; citation_number=12; citation_pages=2235-7; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Methylenetetrahydrofolate reductase C677T mutation, plasma homocysteine, and folate in subjects from northern Italy with or without angiographically documented severe coronary atherosclerotic disease: evidence for an important genetic-environmental interaction.; citation_author=D Girelli; citation_author=S Friso; citation_author=E Trabetti; citation_author=O Olivieri; citation_author=C Russo; citation_journal_title=Blood; citation_volume=91; citation_number=13; citation_pages=4158-63; citation_date=1998; " />
      <meta name="citation_reference" content="citation_title=Low plasma vitamin B-6 concentrations and modulation of coronary artery disease risk.; citation_author=S Friso; citation_author=D Girelli; citation_author=N Martinelli; citation_author=O Olivieri; citation_author=V Lotto; citation_journal_title=Am J Clin Nutr; citation_volume=79; citation_number=14; citation_pages=992-8; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection.; citation_author=A Araki; citation_author=Y Sako; citation_journal_title=J Chromatogr; citation_volume=422; citation_number=15; citation_pages=43-52; citation_date=1987; " />
      <meta name="citation_reference" content="citation_title=Plasma homocysteine levels and mortality in patients with coronary artery disease.; citation_author=O Nygard; citation_author=JE Nordrehaug; citation_author=H Refsum; citation_author=PM Ueland; citation_author=M Farstad; citation_journal_title=N Engl J Med; citation_volume=337; citation_number=16; citation_pages=230-6; citation_date=1997; " />
      <meta name="citation_reference" content="citation_title=Plasma homocysteine predicts mortality independently of traditional risk factors and C-reactive protein in patients with angiographically defined coronary artery disease.; citation_author=JL Anderson; citation_author=JB Muhlestein; citation_author=BD Horne; citation_author=JF Carlquist; citation_author=TL Bair; citation_journal_title=Circulation; citation_volume=102; citation_number=17; citation_pages=1227-32; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=Methionine loading test is necessary for detection of hyperhomocysteinemia.; citation_author=R van der Griend; citation_author=FJ Haas; citation_author=M Duran; citation_author=DH Biesma; citation_author=OJ Meuwissen; citation_journal_title=J Lab Clin Med; citation_volume=132; citation_number=18; citation_pages=67-72; citation_date=1998; " />
      <meta name="citation_reference" content="citation_title=Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project.; citation_author=IM Graham; citation_author=LE Daly; citation_author=HM Refsum; citation_author=K Robinson; citation_author=LE Brattstrom; citation_journal_title=JAMA; citation_volume=277; citation_number=19; citation_pages=1775-81; citation_date=1997; " />
      <meta name="citation_reference" content="citation_title=McPartlin J, Johnston C, Engbaek F, Schneede J, McPartlin C, Scott JM. Facts and recommendations about total homocysteine determinations: an expert opinion.; citation_author=H Refsum; citation_author=AD Smith; citation_author=PM Ueland; citation_author=E Nexo; citation_author=R Clarke; citation_journal_title=Clin Chem; citation_volume=50; citation_number=20; citation_pages=3-32; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a metaanalysis.; citation_author=L Brattström; citation_author=DE Wilcken; citation_author=J Ohrvik; citation_author=L Brudin; citation_journal_title=Circulation; citation_volume=98; citation_number=21; citation_pages=2520-6; citation_date=1998; " />
      <meta name="citation_reference" content="citation_title=“Mendelian randomization”: can genetic epidemiology contribute to understanding environmental determinants of disease?; citation_author=G Davey Smith; citation_author=S Ebrahim; citation_journal_title=Int J Epidemiol; citation_volume=32; citation_number=22; citation_pages=1-22; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=Methylenetetrahydrofolate reductase polymorphism (C677T), hyperhomocysteinemia, and risk of ischemic cardiovascular disease and venous thromboembolism: prospective and case-control studies from the Copenhagen City Heart Study.; citation_author=J Frederiksen; citation_author=K Juul; citation_author=P Grande; citation_author=GB Jensen; citation_author=TV Schroeder; citation_journal_title=Blood; citation_volume=104; citation_number=23; citation_pages=3046-51; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=ACC/AHA guidelines for coronary artery bypass graft surgery: executive summary and recommendations : A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1991 guidelines for coronary artery bypass graft surgery).; citation_author=KA Eagle; citation_author=RA Guyton; citation_author=R Davidoff; citation_author=GA Ewy; citation_author=J Fonger; citation_journal_title=Circulation; citation_volume=100; citation_number=24; citation_pages=1464-80; citation_date=1999; " />
      <meta name="citation_reference" content="citation_title=The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts.; citation_journal_title=N Engl J Med; citation_volume=336; citation_number=25; citation_pages=153-62; citation_date=1997; " />
      <meta name="citation_reference" content="citation_title=Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) Investigators. C-reactive protein levels and outcomes after statin therapy.; citation_author=PM Ridker; citation_author=CP Cannon; citation_author=D Morrow; citation_author=N Rifai; citation_author=LM Rose; citation_journal_title=N Engl J Med; citation_volume=352; citation_number=26; citation_pages=20-8; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Folate metabolism and cardiovascular disease.; citation_author=YM Smulders; citation_author=CD Stehouwer; citation_journal_title=Semin Vasc Med; citation_volume=5; citation_number=27; citation_pages=87-97; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status.; citation_author=S Friso; citation_author=SW Choi; citation_author=D Girelli; citation_author=JB Mason; citation_author=GG Dolnikowski; citation_journal_title=Proc Natl Acad Sci U S A; citation_volume=99; citation_number=28; citation_pages=5606-11; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=Homocysteine trials--clear outcomes for complex reasons.; citation_author=J Loscalzo; citation_journal_title=N Engl J Med; citation_volume=354; citation_number=29; citation_pages=1629-32; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=The effect of folic acid fortification on plasma folate and total homocysteine concentrations.; citation_author=PF Jacques; citation_author=J Selhub; citation_author=AG Bostom; citation_author=PW Wilson; citation_author=IH Rosenberg; citation_journal_title=N Engl J Med; citation_volume=340; citation_number=30; citation_pages=1449-54; citation_date=1999; " />

  <link rel="canonical" href="http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0000083" />

    <meta name="twitter:card" content="summary"/>
    <meta name="twitter:site" content="@plosone"/>
    <meta name="twitter:title" content="Hyperhomocysteinemia and Mortality after Coronary Artery Bypass Grafting"/>
    <meta name="twitter:description" content="BackgroundThe independent prognostic impact, as well as the possible causal role, of hyperhomocysteinemia (HHcy) in coronary artery disease (CAD) is controversial. No previous study specifically has addressed the relationship between HHcy and mortality after coronary artery bypass grafting (CABG) surgery. The aim of this study is to evaluate the prognostic impact of HHcy after CABG surgery.Methodology and Principal FindingsWe prospectively followed 350 patients who underwent elective CABG between May 1996 and May 1999. At baseline, fasting total homocysteine (tHcy) levels were measured in all participants, and a post-methionine loading (PML) test was performed in 77.7% of them (n&#8202;=&#8202;272). After a median follow-up of 58 months, 33 patients (9.4%) had died, 25 because of cardiovascular events. HHcy, defined by levels higher than the 90th percentile (25.2 &micro;mol/L) of the population's distribution, was significantly associated to total and cardiovascular mortality (P&#8202;=&#8202;0.018 [log-rank test 5.57]; P&#8202;=&#8202;0.002 [log-rank test 9.76], respectively). The PML test had no prognostic value. After multiple adjustment for other univariate predictors by Cox regression, including statin therapy (the most powerful predictor in uni-/multivariate analyses), high-sensitivity C Reactive Protein (hs-CRP) levels, and all known major genetic (MTHFR 677C&rarr;T polymorphism) and non-genetic (B-group vitamin status and renal function) tHcy determinants, HHcy remained an independent prognostic factor for mortality (HRs: 5.02, 95% CIs 1.88 to 13.42, P&#8202;=&#8202;0.001).ConclusionsHHcy is an important prognostic marker after CABG, independent of modern drug therapy and biomarkers."/>
      <meta name="twitter:image" content="http://dx.plos.org/10.1371/journal.pone.0000083.g001"/>

  <meta property="og:title" content="Hyperhomocysteinemia and Mortality after Coronary Artery Bypass Grafting" />
  <meta property="og:type" content="article" />
  <meta property="og:url" content="http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0000083" />

 <!--end articleInfoX-->

  <link rel="pingback" href="http://www.plosone.org/pingback" />


  <link rel="shortcut icon" href="/images/favicon.ico" type="image/x-icon"/>
  <link rel="home" title="home" href="/"/>
  <link rel="alternate" type="application/rss+xml"
        title="PLOS ONE: New Articles"
        href="http://www.plosone.org/article/feed"/>
</head>
<body>

  <div id="page-wrap">
    <div id="topbanner" class="cf">

<!-- Div for the ad at the top of journal home page-->
<div class="center">
  <div class="title">Advertisement</div>
  <iframe id='a3ac9da4' name='a3ac9da4'
    src='http://ads.plos.org/www/delivery/afr.php?zoneid=345&amp;cb=4578'
    frameborder='0' scrolling='no' width='730' height='90'>
    <a href='http://ads.plos.org/www/delivery/ck.php?n=a3ac9da4&amp;cb=2782'
      target='_top'><img src='http://ads.plos.org/www/delivery/avw.php?zoneid=345&amp;cb=7650&amp;n=a3ac9da4'
      border='0' alt=''/>
    </a>
  </iframe>
</div>    </div>

    <div id="pagehdr-wrap">
      <div id="pagehdr">
        <div id="user" class="nav">
          <ul>
            <li><a href="http://www.plos.org">plos.org</a></li>
            <li><a href="https://register.plos.org/ambra-registration/register.action">create account</a></li>
            <li class="btn-style"><a
              href="/user/secure/secureRedirect.action?goTo=%2Farticle%2FfetchArticle.action%3FarticleURI%3Dinfo%253Adoi%252F10.1371%252Fjournal.pone.0000083">sign in</a>
            </li>
          </ul>
        </div>
        <div class="logo">
          <a href="/"><img src="/images/logo.png" alt="PLOS ONE"></a>
        </div>

<div id="nav-main" class="nav">
  <ul>
        <li id="mn-01"><a href="/taxonomy" class="areas-link">Subject Areas</a></li>
    <li id="mn-02"><a href="javascript:void(0);">For Authors</a>
      <div class="submenu" style="width: 540px; margin-left: -300px;">
        <div class="block">
          <div class="submit-script">
            <h3>Submit your Manuscript</h3>
            <ul>
              <li>Fair, rigorous peer review</li>
              <li>Broad scope and wide reach</li>
            </ul>
            <a href="/static/submissionInstructions" class="btn">get started</a>
          </div>
        </div>
        <div class="menu">
          <ul>
            <li><a href="/static/publish">Why Publish with PLOS ONE</a></li>
            <li><a href="/static/publication">Publication Criteria</a></li>
            <li><a href="/static/editorial">Editorial Policies</a></li>
            <li><a href="/static/guidelines">Preparing A Manuscript</a></li>
            <li><a href="/static/figureGuidelines">Figure and Table Guidelines</a></li>
          <li><a href="/static/supportingInformation">Supporting Information Guidelines</a></li>
            <li><a href="/static/submissionInstructions">Submitting a Manuscript</a></li>
          </ul>
        </div>
      </div>
    </li>

    <li id="mn-03"><a href="javascript:void(0);">About Us</a>
      <div class="submenu" style="width:248px; margin-left:-30px;">
        <div class="menu">
          <ul>
            <li><a href="/static/information">Journal Information</a></li>
            <li><a href="/static/edboard">Editorial Board</a></li>
            <li><a href="/static/reviewerGuidelines">Reviewer Guidelines</a></li>
            <li><a href="/static/almInfo">Article-Level Metrics</a></li>
            <li><a href="/static/license">Open-Access License</a></li>
            <li><a href="/static/downloads">Media Downloads</a></li>
            <li><a href="/static/commentGuidelines">Guidelines for Comments</a></li>
            <li><a href="/static/corrections">Corrections</a></li>
            <li><a href="/static/help">Help Using this Site</a></li>
            <li><a href="/static/contact">Contact Us</a></li>
          </ul>
        </div>
      </div>
    </li>
  </ul>
<div id="db">
  <form name="searchForm" action="/search/simple?noSearchFlag=true&amp;query=&amp;articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0000083" method="get" >
<input type="hidden" name="from" value="globalSimpleSearch" id="from"/><input type="hidden" name="filterJournals" value="PLoSONE" id="filterJournals"/>    <fieldset>
      <legend>Search</legend>
      <label for="search">Search</label>
      <div class="wrap">
        <input id="search" type="text" name="query" placeholder="Search">
        <input type="image" alt="SEARCH" src="/images/icon.search.gif">
      </div>
    </fieldset>
  </form>
    <a id="advSearch" href="/search/advanced?noSearchFlag=true&amp;query=&amp;articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0000083&filterJournals=PLoSONE">advanced search</a>
</div></div>

      </div>
      <!-- pagehdr-->
    </div>
    <!-- pagehdr-wrap -->

  <!--body and html tags gets closed in global_footer.ftl-->
<script type="text/javascript" src="/javascript/mathjax/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>

<div id="pagebdy-wrap">
  <div id="pagebdy">

    <div id="article-block" class="cf">

<div class="article-meta cf">
  <ul id="almSignPost" style="display: none;"></ul>
  <div class="article-type">
    <span class="type oa">Open Access</span>
      <span class="type pr">Peer-Reviewed</span>
  </div>
</div>

<div class="header" id="hdr-article">

<div class="article-kicker">
      <span id="article-type-heading">
        Research Article
      </span>
</div>  <h1 property="dc:title" datatype="" rel="dc:type" href="http://purl.org/dc/dcmitype/Text">
    Hyperhomocysteinemia and Mortality after Coronary Artery Bypass Grafting
  </h1>

  <ul class="authors">
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Domenico Girelli
              <span class="corresponding">mail</span>, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              <p><span class="email">*</span>To whom correspondence should be addressed. E-mail: <a href="mailto:domenico.girelli@univr.it">domenico.girelli@univr.it</a>
            </p>

                <p>Affiliation:
                  Department of Clinical and Experimental Medicine, University of Verona, Verona, Italy
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Nicola Martinelli, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Department of Clinical and Experimental Medicine, University of Verona, Verona, Italy
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Oliviero Olivieri, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Department of Clinical and Experimental Medicine, University of Verona, Verona, Italy
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Francesca Pizzolo, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Department of Clinical and Experimental Medicine, University of Verona, Verona, Italy
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Simonetta Friso, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Department of Clinical and Experimental Medicine, University of Verona, Verona, Italy
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Giovanni Faccini, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Institutes of Clinical Chemistry, University of Verona, Verona, Italy
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Claudia Bozzini, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Department of Clinical and Experimental Medicine, University of Verona, Verona, Italy
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Ilaria Tenuti, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Department of Clinical and Experimental Medicine, University of Verona, Verona, Italy
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Valentina Lotto, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Department of Clinical and Experimental Medicine, University of Verona, Verona, Italy
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Giuliano Villa, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Department of Clinical and Experimental Medicine, University of Verona, Verona, Italy
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Patrizia Guarini, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Department of Clinical and Experimental Medicine, University of Verona, Verona, Italy
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Elisabetta Trabetti, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Section of Biology and Genetics, University of Verona, Verona, Italy
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Pier Franco Pignatti, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Section of Biology and Genetics, University of Verona, Verona, Italy
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Alessandro Mazzucco, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Cardiovascular Surgery, University of Verona, Verona, Italy
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Roberto Corrocher
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Department of Clinical and Experimental Medicine, University of Verona, Verona, Italy
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
  </ul>
  <ul class="date-doi-line">
    <li>Published: December 20, 2006</li>
    <li>DOI: 10.1371/journal.pone.0000083</li>
  </ul>


</div><!--end header-->
<div class="main cf" id="pjax-container">
  

<div class="nav items-5" id="nav-article">
  <ul>
  <li>
        <span class="active" name="article">Article</span>
  </li>
  <li>
      <a href="/article/authors/info%3Adoi%2F10.1371%2Fjournal.pone.0000083" name="authors">About the Authors</a>
  </li>
  <li>
      <a href="/article/metrics/info%3Adoi%2F10.1371%2Fjournal.pone.0000083" name="metrics">Metrics</a>
  </li>
  <li>
      <a href="/article/comments/info%3Adoi%2F10.1371%2Fjournal.pone.0000083" name="comments">Comments</a>
  </li>
  <li>
      <a href="/article/related/info%3Adoi%2F10.1371%2Fjournal.pone.0000083" name="related">Related Content</a>
  </li>
  </ul>
</div>

<script type="text/javascript">
  var selected_tab = "article";
</script>
  <div id="figure-thmbs" class="carousel cf">
    <div class="wrapper">
      <div class="slider">
              <div class="item">
                <a href="#pone-0000083-t001" data-doi="info:doi/10.1371/journal.pone.0000083" data-uri="info:doi/10.1371/journal.pone.0000083.t001" title="Table 1">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000083.t001&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0000083-t002" data-doi="info:doi/10.1371/journal.pone.0000083" data-uri="info:doi/10.1371/journal.pone.0000083.t002" title="Table 2">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000083.t002&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0000083-g001" data-doi="info:doi/10.1371/journal.pone.0000083" data-uri="info:doi/10.1371/journal.pone.0000083.g001" title="Figure 1">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000083.g001&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0000083-t003" data-doi="info:doi/10.1371/journal.pone.0000083" data-uri="info:doi/10.1371/journal.pone.0000083.t003" title="Table 3A">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000083.t003&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0000083-t004" data-doi="info:doi/10.1371/journal.pone.0000083" data-uri="info:doi/10.1371/journal.pone.0000083.t004" title="Table 3B">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000083.t004&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
      </div>
    </div>
  </div>

  <div class="nav-col">
    <div class="nav" id="nav-article-page">
      <ul>
        <li class="nav-col-comments"><a href="/article/comments/info%3Adoi%2F10.1371%2Fjournal.pone.0000083">Reader Comments (0)</a></li>
          <li id="nav-figures"><a data-doi="info:doi/10.1371/journal.pone.0000083" >Figures</a></li>
      </ul>
    </div>
  </div>

  <div class="article">







<div class="abstract"><a id="abstract0" name="abstract0" toc="abstract0" title="Abstract"></a><h2>Abstract</h2>
<h3>Background</h3>
<a id="article1.front1.article-meta1.abstract1.sec1.p1" name="article1.front1.article-meta1.abstract1.sec1.p1"></a><p>The independent prognostic impact, as well as the possible causal role, of hyperhomocysteinemia (HHcy) in coronary artery disease (CAD) is controversial. No previous study specifically has addressed the relationship between HHcy and mortality after coronary artery bypass grafting (CABG) surgery. The aim of this study is to evaluate the prognostic impact of HHcy after CABG surgery.</p>


<h3>Methodology and Principal Findings</h3>
<a id="article1.front1.article-meta1.abstract1.sec2.p1" name="article1.front1.article-meta1.abstract1.sec2.p1"></a><p>We prospectively followed 350 patients who underwent elective CABG between May 1996 and May 1999. At baseline, fasting total homocysteine (tHcy) levels were measured in all participants, and a post-methionine loading (PML) test was performed in 77.7% of them (n = 272). After a median follow-up of 58 months, 33 patients (9.4%) had died, 25 because of cardiovascular events. HHcy, defined by levels higher than the 90<sup>th</sup> percentile (25.2 µmol/L) of the population's distribution, was significantly associated to total and cardiovascular mortality (<em>P</em> = 0.018 [log-rank test 5.57]; <em>P</em> = 0.002 [log-rank test 9.76], respectively). The PML test had no prognostic value. After multiple adjustment for other univariate predictors by Cox regression, including statin therapy (the most powerful predictor in uni-/multivariate analyses), high-sensitivity C Reactive Protein (hs-CRP) levels, and all known major genetic (<em>MTHFR 677C→T</em> polymorphism) and non-genetic (B-group vitamin status and renal function) tHcy determinants, HHcy remained an independent prognostic factor for mortality (HRs: 5.02, 95% CIs 1.88 to 13.42, <em>P</em> = 0.001).</p>


<h3>Conclusions</h3>
<a id="article1.front1.article-meta1.abstract1.sec3.p1" name="article1.front1.article-meta1.abstract1.sec3.p1"></a><p>HHcy is an important prognostic marker after CABG, independent of modern drug therapy and biomarkers.</p>

</div>


<div class="articleinfo"><p><strong>Citation: </strong>Girelli D, Martinelli N, Olivieri O, Pizzolo F, Friso S, et al.  (2006) Hyperhomocysteinemia and Mortality after Coronary Artery Bypass Grafting. PLoS ONE 1(1):
          e83.
            doi:10.1371/journal.pone.0000083</p><p><strong>Academic Editor: </strong>Thomas Zwaka, Baylor College of Medicine, United States of America</p><p><strong>Received:</strong> October 18, 2006; <strong>Accepted:</strong> November 9, 2006; <strong>Published:</strong> December 20, 2006</p><p><strong>Copyright:</strong> © 2006 Girelli et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p><p><strong>Funding: </strong>Supported by grants from the Veneto Region, MIUR, and the Cariverona Foundation, Verona, Italy.</p><p><strong>Competing interests:</strong> The authors have declared that no competing interests exist.</p></div>





<div id="section1" class="section"><a id="s1" name="s1" toc="s1" title="Introduction"></a><h3>Introduction</h3><a id="article1.body1.sec1.p1" name="article1.body1.sec1.p1"></a><p>Homocysteine is a sulphur-containing amino acid formed as a by-product of methyl-transfer reactions in methionine metabolism <a href="#pone.0000083-Refsum1">[1]</a>. Since proposed in 1969 by McCully <a href="#pone.0000083-McCully1">[2]</a>, the association between serum total homocysteine (tHcy) and coronary artery disease (CAD) has been strongly corroborated by recent meta-analyses of numerous epidemiological studies <a href="#pone.0000083-Homocysteine1">[3]</a>. Nevertheless, the independent prognostic impact of tHcy, as well as its causal role in CAD pathogenesis, remain controversial. Pieces of evidence in favor include basic research studies on animal models indicating that Hcy causes endothelial dysfunction/damage, lipid peroxidation, and accelerated thrombosis [reviewed in 4]. Studies on the common <em>677C→T</em> polymorphism of the Methylentetrahydrofolate reductase (<em>MTHFR</em>) gene, known to be associated with a moderate elevation of tHcy, support a causal link between Hcy and atherosclerosis through the so-called “Mendelian randomization” phenomenon <a href="#pone.0000083-Klerk1">[5]</a>, though some Authors recently disagreed <a href="#pone.0000083-Lewis1">[6]</a>. Critics also emphasize the lack of evidence, from the randomized controlled trials published so far <a href="#pone.0000083-Lange1">[7]</a>–<a href="#pone.0000083-Lonn1">[10]</a>, that lowering tHcy by folic acid-based multivitamin therapy could prevent “hard” vascular outcomes. Finally, it is frequently underscored that the stronger associations between Hcy and vascular risk have been found in cross-sectional or case-control studies rather than in prospective studies <a href="#pone.0000083-Homocysteine1">[3]</a>, <a href="#pone.0000083-Ford1">[11]</a>, which are generally considered superior in supporting causation. Indeed, results from epidemiological studies on cardiovascular patients are often weakened by the wide clinical heterogeneity of the patients enrolled, as well as that of the endpoint considered.</p>
<a id="article1.body1.sec1.p2" name="article1.body1.sec1.p2"></a><p>We endeavored to further evaluate tHcy as secondary risk predictor by studying prospectively a selected homogeneous population of patients undergoing coronary artery by pass grafting (CABG), which remains a cornerstone of CAD therapy even in the percutaneous coronary intervention (PCI) era <a href="#pone.0000083-Gersh1">[12]</a>. Total and cardiovascular mortality were considered as the endpoints.</p>
</div>

<div id="section2" class="section"><a id="s2" name="s2" toc="s2" title="Methods"></a><h3>Methods</h3>
<h4>Study population</h4>
<a id="article1.body1.sec2.sec1.p1" name="article1.body1.sec2.sec1.p1"></a><p>The Verona Heart Project is a study aimed to search for new risk factors for CAD in a population of subjects with objective angiographic documentation of their coronary vessels. Details about the enrolment criteria have been described elsewhere <a href="#pone.0000083-Girelli1">[13]</a>. In the present study we used data from a total of 353 consecutive adult patients of both sexes, who underwent to CABG at the Cardiosurgery Unit of Verona between May 1996 and May 1999. Angiographic CAD was assessed by two cardiologists unaware that the patients were to be included in the study. The majority of patients (93.4%) had severe multi-vessel CAD (stenosis≥50% of the vessel diameter in two or three of the main coronary arteries). All participants came from the same geographical area (Northern Italy), with a similar socio-economic background. They were enrolled at scheduled ambulatory evaluation few days before elective CABG surgery. At that time, blood sampling and a complete clinical history was collected, including the assessment of classical cardiovascular risk factors. The diagnosis of previous myocardial infarction was based on a thorough review of the medical history, previous ECG, and enzyme documentation, and/or based on the finding of typical sequelae of infarction on ventricular angiography. Left ventricular ejection fraction (LVEF) was estimated by ventriculography and/or echocardiography. To avoid any bias in tHcy measurement, we enrolled only subjects who were not treated with vitamin supplementation or drugs interfering with tHcy levels (i.e., anticonvulsivants, methotrexate and penicillamine) <a href="#pone.0000083-Girelli1">[13]</a>. Similarly, none of the enrolled subjects had any major systemic acute illness, including myocardial infarction (MI), in the preceding 3 months. The study was approved by the Ethical Committee of our Hospital. Informed consent was obtained from all the patients after a full explanation of the study.</p>


<h4>Assessment of outcome</h4>
<a id="article1.body1.sec2.sec2.p1" name="article1.body1.sec2.sec2.p1"></a><p>Subjects were followed until death or May 2004. Study subjects status was determined by search of the national population register, and by an ambulatory or telephone survey. Ascertainment of mortality status was complete (100 percent). The date of death was obtained from the National Population Register. The causes of death were obtained from death certificates kept at the Italian Institute of Statistics (ISTAT). Death from cardiovascular causes was defined as death caused by CAD, heart failure, peripheral vascular disease, or cerebrovascular disease. Three subjects died peri-operatively (during hospitalization and/or within one month from surgery), so that they were excluded from the survival analysis.</p>


<h4>Laboratory testing</h4>
<a id="article1.body1.sec2.sec3.p1" name="article1.body1.sec2.sec3.p1"></a><p>Samples of venous blood were drawn from each subject after an overnight fast. Serum lipids, other routine biochemical parameters including creatinine, as well as plasma folate, vitamin B12, and the <em>MTHFR 677C→T</em> polymorphism were determined as previously described <a href="#pone.0000083-Girelli1">[13]</a>. The four variable version of the Modification of Diet in Renal Disease (MDRD) equation was used to estimate the glomerular filtration rate (GFR) from serum creatinine levels. Vitamin B6 was measured by high-pressure liquid chromatography (HPLC) with fluorometric detection <a href="#pone.0000083-Friso1">[14]</a>. High-sensitivity C-reactive protein (hs-CRP) was measured by particle-enhanced nephelometric immunoassay (Dade-Behring Inc., Newark, DE). For tHcy (which refers to the sum of homocysteine, homocystine, and homocysteine-cysteine mixed disulfide, free and protein bound), blood was collected into EDTA-containing vacuum tubes and kept on ice and in the dark; plasma was separated within 90 minutes; tHcy levels were determined by HPLC with fluorometric detection, as described <a href="#pone.0000083-Girelli1">[13]</a>, <a href="#pone.0000083-Araki1">[15]</a>. In 272 subjects, after the first blood sampling, a standardized methionine-loading test was performed by administering orally L-methionine (100 mg/kg) mixed with 200 ml of orange juice, together with a standardized low-protein breakfast; blood was then collected 6 hours later for the determination of the post-methionine loading (PML) tHcy level.</p>


<h4>Statistics</h4>
<a id="article1.body1.sec2.sec4.p1" name="article1.body1.sec2.sec4.p1"></a><p>All the calculations were performed with SSPS 13.0 statistical package (SPSS Inc., Chicago, IL). Distributions of continuous variables in groups were expressed as means±standard deviation. Logarithmic transformation was performed on all skewed variables, including tHcy, folate, vitamin B12, vitamin B6 and hs-CRP. Hence, geometric means with 95% confidence intervals (CIs) are given for these variables. Quantitative data were assessed using the Student's t-test, or by ANOVA with Tukey's post-hoc test when appropriate. Associations between qualitative variables were analyzed with the χ<sup>2</sup> test. Correlations between quantitative variables were assessed using Pearson's correlation test. Significant associations between tHcy levels and other continuous or categorical variables, were assessed by multiple regression models estimating R<sup>2</sup> and standardized β-coefficients. Categorical variables were used after transformation into binary variables (i.e. for <em>MTHFR 677C→T</em> polymorphism we considered homozygosity versus non-homozygosity for the T allele). Hyperhomocysteinemia (HHcy) was defined by tHcy levels higher than the 90<sup>th</sup> percentile of population's distribution, i.e. ≥25.2 µmol/l. Survival was assessed by the Kaplan-Meier method (log-rank statistic) and Cox regression. Kaplan-Meier methods were used for survival plots. Multivariate Cox proportional hazards analyses were performed considering sex, age, other tHcy determinants (MTHFR genotype, B-vitamin levels, GFR), and all predictors of mortality at univariate analyses, including drug therapy at discharge. Final models were obtained by a backward stepwise logistic regression approach, with <em>P</em> = 0.10 as the critical value for entering/excluding variables in the model. Hazard ratios (HRs) and 95% CIs are reported with two-tailed probability values. A <em>P</em> value less than 0.05 was used to indicate statistical significance.</p>

</div>

<div id="section3" class="section"><a id="s3" name="s3" toc="s3" title="Results"></a><h3>Results</h3>
<h4>Characteristics of the patients</h4>
<a id="article1.body1.sec3.sec1.p1" name="article1.body1.sec3.sec1.p1"></a><p>
               <a href="#pone-0000083-t001">Table 1</a> (left column) shows the complete clinical and biochemical characteristics at baseline of the patient's population (n = 350) after exclusion of peri-operative deaths (n = 3; tHcy values: 18.6, 11.7, and 11.4 µmol/l, respectively). The mean age of patients was 60.2±8.9 years, 82.9% were males, 61.8% had had a previous MI, 93.4% had multi-vessel disease. They had a substantial burden of traditional cardiovascular risk factors, such as smoking (65.6%), hypertension (66.2%), and so on. Patients with HHcy were similar to the others in age, sex, degree of CAD, history of MI before CABG, drug therapy at discharge, and most other traditional risk factors (<a href="#pone-0000083-t001">Table 1</a>, right columns). On the other hand, HHcy patients had decreased GFR and B-vitamin levels, while hs-CRP levels and homozygosity for the <em>T</em> allele of <em>MTHFR</em> were increased. The PML increase of tHcy over basal levels (Δ PML tHcy) was similar in the two groups.</p>
<div class="figure" id="pone-0000083-t001"><div class="img"><a name="pone-0000083-t001" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000083.t001&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0000083" data-uri="info:doi/10.1371/journal.pone.0000083.t001"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000083.t001&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000083.t001/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000083.t001/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000083.t001/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000083.t001/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0000083.t001.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000083.t001/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000083.t001/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0000083.t001.TIF"></span>)
                </a></li></ul></div><p><strong>Table 1.  <span>Clinical and laboratory characteristics of patients by baseline tHcy (90<sup>th</sup> percentile = 25.2 µmol/l).</span></strong></p><span>doi:10.1371/journal.pone.0000083.t001</span></div>

<h4>Determinants of homocysteine levels</h4>
<a id="article1.body1.sec3.sec2.p1" name="article1.body1.sec3.sec2.p1"></a><p>Fasting tHcy levels correlated positively with hs-CRP (<em>r</em> = 0.143, <em>P</em> = 0.008), and negatively with levels of folate (<em>r</em> = −0.330, <em>P</em>&lt;0.001), vitamin B12 (<em>r</em> = −0.207, <em>P</em>&lt;0.001), and estimated GFR (<em>r</em> = −0.226, <em>P</em>&lt;0.001). The relations with vitamin B6 levels (<em>r</em> = −0.097, <em>P</em> = 0.077) and with age (<em>r</em> = 0.096, <em>P</em> = 0.072) were not significant. As expected, <em>MTHFR 677TT</em> subjects had increased mean levels of tHcy (20.5 µmol/l, 95% CIs 17.8 to 23.5) as compared to either <em>677CT</em> (15.5 µmol/l, 95% CIs 14.7 to 16.2) or <em>677CC</em> (14.1 µmol/l, 95% CIs 13.2 to 15.0) subjects (P&lt;0.001 by ANOVA with Tukey post-hoc test). A multiple regression model including all the above mentioned variables showed folate, vitamin B12, GFR, and <em>MTHFR TT</em> homozygosity, as independent predictors of tHcy levels (<a href="#pone-0000083-t002">Table 2</a>).</p>
<div class="figure" id="pone-0000083-t002"><div class="img"><a name="pone-0000083-t002" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000083.t002&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0000083" data-uri="info:doi/10.1371/journal.pone.0000083.t002"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000083.t002&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000083.t002/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000083.t002/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000083.t002/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000083.t002/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0000083.t002.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000083.t002/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000083.t002/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0000083.t002.TIF"></span>)
                </a></li></ul></div><p><strong>Table 2.  <span>Predictors of tHcy levels (dependent variable) in multiple linear regression analysis.</span></strong></p><span>doi:10.1371/journal.pone.0000083.t002</span></div>

<h4>Mortality by baseline tHcy levels</h4>
<a id="article1.body1.sec3.sec3.p1" name="article1.body1.sec3.sec3.p1"></a><p>After a median follow-up of 58 months (range 3 to 87), 33 patients (9.4%) had died. Twenty-five deaths (75.8% of total deaths) were because of cardiovascular events. The 8 deaths due to noncardiovascular causes were mainly due to cancer (6), one patient died from pneumonia, and one from undetermined cause (he had moved to another country and died there, so that we could not retrieve adequate information). The prevalence of HHcy was significantly higher in total and cardiovascular mortality groups (21.2% and 28.0%, respectively) as compared to survivors (8.8%; <em>P</em>&lt;0.05 by χ<sup>2</sup>-test in both cases). In HHcy patients, mortality was nearly twice (20%) as much than in the others, and all deaths in HHcy group were from cardiovascular causes (<a href="#pone-0000083-t001">Table 1</a>). The univariate HRs of HHcy for total and cardiovascular mortality were 2.64, 95% CIs 1.14 to 6.10 (<em>P</em> = 0.023), and 3.67, 95% CIs 1.53 to 8.76 (<em>P</em> = 0.004), respectively. <a href="#pone-0000083-g001">Figures 1A and 1C</a> represent the Kaplan-Meier survival plots for total and cardiovascular mortality of HHcy patients as compared to the others (log-rank statistic = 5.57, <em>P</em> = 0.018; and 9.76, <em>P</em> = 0.002, respectively). Since literature often consider a tHcy level of 15 µmol/l as the upper limit beyond which the cardiovascular risk may start to increase <a href="#pone.0000083-Refsum1">[1]</a>, we further stratified our population with tHcy&lt;25.2 µmol/l into two subgroups with (<em>n</em> = 139) or without (<em>n</em> = 176) baseline tHcy levels≥15 µmol/l. However, with respect to either total or cardiovascular (<a href="#pone-0000083-g001">Figures 1B and 1D</a>) mortality, the group with tHcy between 15 and 25.2 µmol/l behave similarly to the group with tHcy &lt;15 µmol/l, and significantly different from that with tHcy≥25.2 µmol/l.</p>
<div class="figure" id="pone-0000083-g001"><div class="img"><a name="pone-0000083-g001" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000083.g001&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0000083" data-uri="info:doi/10.1371/journal.pone.0000083.g001"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000083.g001&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000083.g001/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000083.g001/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000083.g001/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000083.g001/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0000083.g001.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000083.g001/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000083.g001/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0000083.g001.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 1.  <span>Kaplan-Meier survival plots for total mortality (A–B) and cardiovascular death (C–D) in relation to tHcy levels.</span></strong></p><a id="article1.body1.sec3.sec3.fig1.caption1.p1" name="article1.body1.sec3.sec3.fig1.caption1.p1"></a><p>Cutoff points for tHcy strata at 25.2 µmol/l in plots A and C, at 15 and 25.2 µmol/l in plots B and D.</p>
<span>doi:10.1371/journal.pone.0000083.g001</span></div>

<h4>Other univariate predictors</h4>
<a id="article1.body1.sec3.sec4.p1" name="article1.body1.sec3.sec4.p1"></a><p>Statin therapy at discharge was the most powerful prognostic indicator (HRs for total and cardiovascular mortality = 0.14, 95% CIs 0.06 to 0.33; <em>P</em>&lt;0.001; and 0.20, 95% CIs 0.08 to 0.50; <em>P</em> = 0.001). Other predictive factors in univariate analyses were hs-CRP levels, age, LVEF, and β-blocker therapy at discharge. Details about the relative HRs with 95% CIs are shown in <a href="#pone-0000083-t003">Table 3A</a>, together with values adjusted for age and sex. The <em>MTHFR 677TT</em> genotype was not significantly associated to an increased mortality, while we observed a non significant trend toward the contrary: for example, the prevalence of <em>TT</em> genotype was only 6.3% in the total mortality group, 8.3% in the group died for cardiovascular causes, as compared to 17.5% in survivors (<em>P</em> = NS). Moreover, none of the other determinants of tHcy in the multiple regression model (folate, vitamin B12) showed a predictive value at a <em>P</em> level&lt;0.10).</p>
<div class="figure" id="pone-0000083-t003"><div class="img"><a name="pone-0000083-t003" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000083.t003&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0000083" data-uri="info:doi/10.1371/journal.pone.0000083.t003"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000083.t003&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000083.t003/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000083.t003/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000083.t003/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000083.t003/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0000083.t003.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000083.t003/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000083.t003/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0000083.t003.TIF"></span>)
                </a></li></ul></div><p><strong>Table 3A.  <span>Univariate and sex/age adjusted predictors of total and cardiovascular mortality by Cox regression analyses.</span></strong></p><span>doi:10.1371/journal.pone.0000083.t003</span></div>

<h4>Multivariate predictive models</h4>
<a id="article1.body1.sec3.sec5.p1" name="article1.body1.sec3.sec5.p1"></a><p>
               <a href="#pone-0000083-t004">Table 3B</a> shows the final multivariate Cox predictive models for total and cardiovascular mortality, obtained by backward stepwise logistic regression approach (<em>P</em>≥0.10 to remove). All univariate predictors of total or cardiovascular mortality with <em>P</em>&lt;0.10 (<a href="#pone-0000083-t003">Table 3A</a>), including sex, history of myocardial infarction, and all the significant predictors of tHcy (<em>MTHFR</em> genotype, glomerular filtration rate, folate, and vitamin B12) were initially entered. Statin therapy was confirmed as the most significant protective predictor. Noteworthy, in multivariate models hs-CRP levels were no longer independent predictors of either total or cardiovascular mortality. Additional stepwise models revealed that this loss of statistical significance was due to adjustment for statin therapy (data not shown). On the contrary, HHcy remained a significant independent predictor even after adjustment for all potential confounders, including major tHcy determinants such as GFR, folate, vitamin B12, and <em>MTHFR 677 TT</em> genotype (<a href="#pone-0000083-t004">Table 3B</a>).</p>
<div class="figure" id="pone-0000083-t004"><div class="img"><a name="pone-0000083-t004" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000083.t004&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0000083" data-uri="info:doi/10.1371/journal.pone.0000083.t004"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000083.t004&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000083.t004/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000083.t004/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000083.t004/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000083.t004/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0000083.t004.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000083.t004/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000083.t004/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0000083.t004.TIF"></span>)
                </a></li></ul></div><p><strong>Table 3B.  <span>Final Cox predictive models of total and cardiovascular mortality.</span></strong></p><span>doi:10.1371/journal.pone.0000083.t004</span></div>
</div>

<div id="section4" class="section"><a id="s4" name="s4" toc="s4" title="Discussion"></a><h3>Discussion</h3><a id="article1.body1.sec4.p1" name="article1.body1.sec4.p1"></a><p>In this prospective study, hyperhomocysteinemia (&gt;25.2 µmol/l) was an important and independent prognostic factor of mortality after CABG. A particular effort was made to take into account all possible confounders, including the known major genetic (<em>MTHFR 677C→T</em> polymorphism) and non-genetic (renal function, B-group vitamin status) determinants of tHcy, as well as modern drug therapy. To put our results into perspective from a clinical standpoint, we propose the following considerations.</p>

<h4>Comparison with previous studies</h4>
<a id="article1.body1.sec4.sec1.p1" name="article1.body1.sec4.sec1.p1"></a><p>Most of the prospective studies published so far on tHcy focused on subjects without evident cardiovascular disease at entry, yielding variable results <a href="#pone.0000083-Homocysteine1">[3]</a>, <a href="#pone.0000083-Ford1">[11]</a>. Relatively few studies <a href="#pone.0000083-Nygard1">[16]</a>, <a href="#pone.0000083-Anderson1">[17]</a> focused on patients with angiographically defined CAD, and none of them specifically addressed the prognostic impact of tHcy after CABG. Nygard et al. <a href="#pone.0000083-Nygard1">[16]</a> evaluated mortality in 587 patients with angiographically defined CAD, 318 of them submitted to CABG. After a median follow-up of 4.6 years, they found in the entire population a 10.9% total mortality, with a ratio of 4.5 for patients with the highest (&gt;20 µmol/l) compared to the lowest (&lt;9 µmol/l) tHcy values, after adjustment for traditional risk factors. Anderson et al. <a href="#pone.0000083-Anderson1">[17]</a> studied a total of 1,412 patients after a median follow-up of 3 years from angiography (total deaths: 11.8%), subsequently treated by CABG, angioplasty, or medical therapy alone. In the entire group, subjects with elevated tHcy (mean level 22.9 µmol/l) had a significant mortality risk, but no specific data were given for the CABG subgroup. Our results are well in line with these studies, indicating HHcy as a prognostic marker of mortality in high-risk CAD patients. Moreover, our multivariate adjustment included newer prognostic factors like hs-CRP, major genetic and non-genetic determinant of tHcy levels (<em>MTHFR</em> 
               <em>677C→T</em> polymorphism, B group vitamins, renal function), and details on current drug therapy after CABG. The predictive value of tHcy remained statistically significant even after correction for a major determinant of mortality such as statin therapy.</p>
<a id="article1.body1.sec4.sec1.p2" name="article1.body1.sec4.sec1.p2"></a><p>The PML test has been suggested as an useful tool to uncover subtle abnormalities of the homocysteine metabolic pathway <a href="#pone.0000083-vanderGriend1">[18]</a>. In case-control studies, it was reported to identify up to an additional 27% of potentially “at-risk” patients with normal fasting tHcy levels <a href="#pone.0000083-Graham1">[19]</a>. In the routine clinical setting, however, the value of the PML test has been defined “uncertain” by a recent expert panel <a href="#pone.0000083-Refsum2">[20]</a>, which particularly underscored the lack of prospective studies. To the best of our knowledge, this is the first prospective study evaluating the prognostic impact of PML test in CAD patients. Neither PML tHcy absolute values, nor the relative tHcy increase, gave significant predictive information in addition to fasting tHcy. Thus, our data suggest a little value of this cumbersome procedure in the practical scenario.</p>


<h4>MTHFR and risk</h4>
<a id="article1.body1.sec4.sec2.p1" name="article1.body1.sec4.sec2.p1"></a><p>Despite being confirmed as a major independent predictor of hyperhomocysteinemia, the <em>MTHFR 677TT</em> genotype was not at all a predictor of mortality, even in univariate analysis. Meta-analyses have quantified into ~2.5 µmol/l the usual <em>mean</em> increase in tHcy levels of TT <em>versus</em> CC subjects at a population level <a href="#pone.0000083-Brattstrm1">[21]</a>. As a consequence, several thousands of subjects need to be prospectively followed to see an effect on mortality, which, if present, may indicate a causal link between tHcy and CVD because of the so-called “Mendelian Randomization” <a href="#pone.0000083-DaveySmith1">[22]</a>. Our study was clearly underpowered for such a purpose, this being likely the main reason for the null finding. On the other hand, we previously demonstrated in this population a substantial gene-environment interaction, so that the <em>MTHFR 677C→T</em> polymorphism increased tHcy levels only in individuals with low folate status, while it was neutral in individuals with adequate folate levels <a href="#pone.0000083-Girelli1">[13]</a>. Such an effect was confirmed by a recent meta-analysis <a href="#pone.0000083-Klerk1">[5]</a>, revealing that the relation between the <em>MTHFR</em> genotypes and CAD, if any exists, is a complex phenomenon whit marked inter-individual variations. Thus, our null finding for <em>MTHFR</em> genotypes and mortality is not at all surprising, and in line with the reports from Anderson (mortality in <em>MTHFR 677TT versus</em> 
               <em>677CC</em> subjects = 11.7% <em>versus</em> 15.1%, <em>P</em> = 0.62) <a href="#pone.0000083-Anderson1">[17]</a>, and from others who observed divergent associations with incident CAD when considering tHcy or the <em>MTHFR 677C→T</em> polymorphism <a href="#pone.0000083-Frederiksen1">[23]</a>.</p>


<h4>Other predictors of mortality in post-CABG patients</h4>
<a id="article1.body1.sec4.sec3.p1" name="article1.body1.sec4.sec3.p1"></a><p>In this study, statin therapy was the most powerful independent predictor of mortality (Relative Risk Reduction in fully adjusted models: 76–85%). About 60% of our patients, recruited between 1996 and 1999, assumed statin therapy, which was formally introduced as a recommendation into guidelines for CABG surgery only in 1999 <a href="#pone.0000083-Eagle1">[24]</a>. Our data are consistent with previous observations in CABG patients <a href="#pone.0000083-The1">[25]</a>. High-sensitivity CRP, recognized as an important predictor of cardiovascular events in the past few years, was significantly associated to mortality in univariate, and age/sex adjusted, analyses. However, statistical significance was no longer evident after adjustment for statin therapy. This probably reflect the recently highlighted CRP-lowering effect of statins, in a manner largely independent of LDL cholesterol levels <a href="#pone.0000083-Ridker1">[26]</a>.</p>


<h4>tHcy and risk: pathopysiological considerations</h4>
<a id="article1.body1.sec4.sec4.p1" name="article1.body1.sec4.sec4.p1"></a><p>The association between hyperhomocysteinemia and mortality after CABG represents a clue, but not a proof, of causality. Recently, large randomized trials showed no clinical benefit of tHcy-lowering by means of B-group vitamins in secondary prevention <a href="#pone.0000083-Bonaa1">[9]</a>, <a href="#pone.0000083-Lonn1">[10]</a>. Of note, however, they enrolled patients irrespective of their baseline tHcy levels, that were generally low (means: 12.2 to 13.2 µmol/l). On the other hand, in our study a well-defined detrimental role of tHcy was evident only for relatively high levels (&gt;25 µmol/l), consistent with those with the highest predictive value on mortality in previous studies on patients with established CAD (see above) <a href="#pone.0000083-Nygard1">[16]</a>, <a href="#pone.0000083-Anderson1">[17]</a>. Accordingly, experimental studies on endothelial function in humans suggest that the toxicity of tHcy may be barely discernible at levels only slightly elevated <a href="#pone.0000083-Smulders1">[27]</a>. These considerations may indicate the need of focusing future trials with tHcy-lowering therapy on CAD subjects with more than a slight hyperhomocysteinemia. Nevertheless, it is increasingly recognized that therapy with B-group vitamins interferes with complex phenomena, such as nucleic acid synthesis and DNA methylation <a href="#pone.0000083-Smulders1">[27]</a>, <a href="#pone.0000083-Friso2">[28]</a>, suggesting caution, as well as the need of alternative approaches <a href="#pone.0000083-Loscalzo1">[29]</a>.</p>


<h4>Study strength and limitations</h4>
<a id="article1.body1.sec4.sec5.p1" name="article1.body1.sec4.sec5.p1"></a><p>A limitation of this study lies on the relatively low number of events. It also implies the limitations of nonrandomized observational studies (i.e., unsuspected selection biases and confounding), and possible inaccuracy in assigning causes of death by certificates. Nevertheless, it has some advantages. First, the clinical homogeneity of the sample (post-CABG patients with advanced atherosclerosis), which, on the other hand, may well represent the real world. Indeed, in terms of age, and burden of classical risk factors (see <a href="#pone-0000083-t001">table 1</a>), our patients fit the typical profile of CAD patients that are seen by cardiologists and cardiosurgeons in daily practice. A second point of strength is the robustness of the endpoint considered, i.e. mortality. By contrast with these points, previous prospective studies on tHcy often included a larger number of CAD patients, but with a wide clinical heterogeneity (different degree of CAD, age at disease onset, interventional or medical therapy), as well as with artificially combined outcomes (cardiovascular “events”, angiographic restenosis, and so on). Further potential advantages of this study are the full adjustment for modern medical treatment and predictors, as well as, for genetic and non-genetic determinants of tHcy, and the absence of confounding from vitamin supplementation. As mentioned above, nowadays the prognostic impact of tHcy may become hard to evaluate in populations such as those from Northern America, where (differently from Europe) folic acid fortification of grain products issued by FDA in 1996 has been demonstrated to effectively reduce tHcy levels <a href="#pone.0000083-Jacques1">[30]</a>.</p>


<h4>Conclusions</h4>
<a id="article1.body1.sec4.sec6.p1" name="article1.body1.sec4.sec6.p1"></a><p>Irrespective of causality, hyperhomocysteinemia appears as a prognostic marker of mortality after CABG. Its effect was independent of the most significant predictor, which was represented by the lipid-lowering, and probably anti-inflammatory, therapy with statins. Measuring tHcy before CABG may help to identify a high-risk subgroup of patients for whom it may be especially important to follow a healthy lifestyle and diet, as well as to receive optimal treatments for known causal risk factors. Further studies with adequate design are needed to clarify whether or not patients with HHcy should take advantage from tHcy-lowering therapy, as well as to identify the tHcy threshold level that would be worth to treat, to reduce mortality after CABG.</p>

</div>





<div><a id="ack" name="ack" toc="ack" title="Acknowledgments"></a><h3>Acknowledgments</h3>
<a id="article1.back1.ack1.p1" name="article1.back1.ack1.p1"></a><p>We wish to thank Mrs. Maria Zoppi for invaluable secretary help.</p>
</div><div class="contributions"><a id="authcontrib" name="authcontrib" toc="authcontrib" title="Author Contributions"></a><h3>Author Contributions</h3><p>Conceived and designed the experiments: DG NM. Analyzed the data: DG NM GF. Contributed reagents/materials/analysis tools: OO FP SF CB IT VL GV PG ET PP AM. Wrote the paper: DG NM. Other: Patient selection, recruitment and data collection: CB IT VL GV AM. Patient selection, recruitment and data collection, subsequent manuscript discussion: OO FP SF. Molecular biology, subsequent data and manuscript discussion: ET PP. Biochemical assay, subsequent data and manuscript discussion: GF PG. Collection, subsequent manuscript discussion: RC. Critical review of the paper: OO RC.</p></div><div><a id="references" name="references" toc="references" title="References"></a><h3>References</h3><ol class="references"><li><span class="label">1.
              </span><a name="pone.0000083-Refsum1" id="pone.0000083-Refsum1"></a>Refsum H, Ueland PM, Nygard O, Vollset SE (1998) Homocysteine and cardiovascular disease. Annu Rev Med  49: 31–62.  <ul class="find" data-citedArticleID="919640" data-doi="10.1146/annurev.med.49.1.31"><li><a href="http://dx.doi.org/10.1146/annurev.med.49.1.31" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Homocysteine+and+cardiovascular+disease." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Homocysteine+and+cardiovascular+disease.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">2.
              </span><a name="pone.0000083-McCully1" id="pone.0000083-McCully1"></a>McCully KS (1969) Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol  56: 111–28.  <ul class="find" data-citedArticleID="919636"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Vascular+pathology+of+homocysteinemia%3A+implications+for+the+pathogenesis+of+arteriosclerosis.&amp;auth=&amp;atitle=Vascular+pathology+of+homocysteinemia%3A+implications+for+the+pathogenesis+of+arteriosclerosis." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Vascular+pathology+of+homocysteinemia%3A+implications+for+the+pathogenesis+of+arteriosclerosis." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Vascular+pathology+of+homocysteinemia%3A+implications+for+the+pathogenesis+of+arteriosclerosis.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">3.
              </span><a name="pone.0000083-Homocysteine1" id="pone.0000083-Homocysteine1"></a>Homocysteine Studies Collaboration (2002) Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA  288: 2015–22.  <ul class="find" data-citedArticleID="919622" data-doi="10.1001/jama.288.16.2015"><li><a href="http://dx.doi.org/10.1001/jama.288.16.2015" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Homocysteine+and+risk+of+ischemic+heart+disease+and+stroke%3A+a+meta-analysis." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Homocysteine+and+risk+of+ischemic+heart+disease+and+stroke%3A+a+meta-analysis.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">4.
              </span><a name="pone.0000083-Welch1" id="pone.0000083-Welch1"></a>Welch GN, Loscalzo J (1998) Homocysteine and atherothrombosis. N Engl J Med  338: 1042–50.  <ul class="find" data-citedArticleID="919652" data-doi="10.1056/nejm199804093381507"><li><a href="http://dx.doi.org/10.1056/nejm199804093381507" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Homocysteine+and+atherothrombosis." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Homocysteine+and+atherothrombosis.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">5.
              </span><a name="pone.0000083-Klerk1" id="pone.0000083-Klerk1"></a>Klerk M, Verhoef P, Clarke R, Blom HJ, Kok FJ, et al.  (2002) MTHFR 677C→T polymorphism and risk of coronary heart disease: a meta-analysis. JAMA  288: 2023–31.  <ul class="find" data-citedArticleID="919626" data-doi="10.1001/jama.288.16.2023"><li><a href="http://dx.doi.org/10.1001/jama.288.16.2023" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=MTHFR+677C%26%23x2192%3BT+polymorphism+and+risk+of+coronary+heart+disease%3A+a+meta-analysis." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22MTHFR+677C%26%23x2192%3BT+polymorphism+and+risk+of+coronary+heart+disease%3A+a+meta-analysis.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">6.
              </span><a name="pone.0000083-Lewis1" id="pone.0000083-Lewis1"></a>Lewis SJ, Ebrahim S, Davey Smith G (2005) Meta-analysis of MTHFR 677C→T polymorphism and coronary heart disease: does totality of evidence support causal role for homocysteine and preventive potential of folate? BMJ  331: 1053–8.  <ul class="find" data-citedArticleID="919630" data-doi="10.1136/bmj.38611.658947.55"><li><a href="http://dx.doi.org/10.1136/bmj.38611.658947.55" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Meta-analysis+of+MTHFR+677C%26%23x2192%3BT+polymorphism+and+coronary+heart+disease%3A+does+totality+of+evidence+support+causal+role+for+homocysteine+and+preventive+potential+of+folate%3F" target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Meta-analysis+of+MTHFR+677C%26%23x2192%3BT+polymorphism+and+coronary+heart+disease%3A+does+totality+of+evidence+support+causal+role+for+homocysteine+and+preventive+potential+of+folate%3F%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">7.
              </span><a name="pone.0000083-Lange1" id="pone.0000083-Lange1"></a>Lange H, Suryapranata H, De Luca G, Borner C, Dille J, et al.  (2004) Folate therapy and in-stent restenosis after coronary stenting. N Engl J Med  350: 2673–81.  <ul class="find" data-citedArticleID="919628" data-doi="10.1056/nejmoa032845"><li><a href="http://dx.doi.org/10.1056/nejmoa032845" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Folate+therapy+and+in-stent+restenosis+after+coronary+stenting." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Folate+therapy+and+in-stent+restenosis+after+coronary+stenting.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">8.
              </span><a name="pone.0000083-Toole1" id="pone.0000083-Toole1"></a>Toole JF, Malinow MR, Chambless LE, Spence JD, Pettigrew LC, et al.  (2004) Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA  291: 565–75.  <ul class="find" data-citedArticleID="919650" data-doi="10.1001/jama.291.5.565"><li><a href="http://dx.doi.org/10.1001/jama.291.5.565" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Lowering+homocysteine+in+patients+with+ischemic+stroke+to+prevent+recurrent+stroke%2C+myocardial+infarction%2C+and+death%3A+the+Vitamin+Intervention+for+Stroke+Prevention+%28VISP%29+randomized+controlled+trial." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Lowering+homocysteine+in+patients+with+ischemic+stroke+to+prevent+recurrent+stroke%2C+myocardial+infarction%2C+and+death%3A+the+Vitamin+Intervention+for+Stroke+Prevention+%28VISP%29+randomized+controlled+trial.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">9.
              </span><a name="pone.0000083-Bonaa1" id="pone.0000083-Bonaa1"></a>Bonaa KH, Njolstad I, Ueland PM, Schirmer H, Tverdal A, et al.  (2006) Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med  354: 1578–88.  <ul class="find" data-citedArticleID="919600" data-doi="10.1056/nejmoa055227"><li><a href="http://dx.doi.org/10.1056/nejmoa055227" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Homocysteine+lowering+and+cardiovascular+events+after+acute+myocardial+infarction." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Homocysteine+lowering+and+cardiovascular+events+after+acute+myocardial+infarction.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">10.
              </span><a name="pone.0000083-Lonn1" id="pone.0000083-Lonn1"></a>Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, et al.  (2006) Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med  354: 1567–77.  <ul class="find" data-citedArticleID="919632" data-doi="10.1056/nejmoa060900"><li><a href="http://dx.doi.org/10.1056/nejmoa060900" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Homocysteine+lowering+with+folic+acid+and+B+vitamins+in+vascular+disease." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Homocysteine+lowering+with+folic+acid+and+B+vitamins+in+vascular+disease.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">11.
              </span><a name="pone.0000083-Ford1" id="pone.0000083-Ford1"></a>Ford ES, Smith SJ, Stroup DF, Steinberg KK, Mueller PW, et al.  (2002) Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies. Int J Epidemiol  31: 59–70.  <ul class="find" data-citedArticleID="919608" data-doi="10.1093/ije/31.1.59"><li><a href="http://dx.doi.org/10.1093/ije/31.1.59" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Homocyst%28e%29ine+and+cardiovascular+disease%3A+a+systematic+review+of+the+evidence+with+special+emphasis+on+case-control+studies+and+nested+case-control+studies." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Homocyst%28e%29ine+and+cardiovascular+disease%3A+a+systematic+review+of+the+evidence+with+special+emphasis+on+case-control+studies+and+nested+case-control+studies.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">12.
              </span><a name="pone.0000083-Gersh1" id="pone.0000083-Gersh1"></a>Gersh BJ, Frye RL (2005) Methods of coronary revascularization. Things may not be as they seem. N Engl J Med  352: 2235–7.  <ul class="find" data-citedArticleID="919616" data-doi="10.1056/nejme058053"><li><a href="http://dx.doi.org/10.1056/nejme058053" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Methods+of+coronary+revascularization.+Things+may+not+be+as+they+seem." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Methods+of+coronary+revascularization.+Things+may+not+be+as+they+seem.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">13.
              </span><a name="pone.0000083-Girelli1" id="pone.0000083-Girelli1"></a>Girelli D, Friso S, Trabetti E, Olivieri O, Russo C, et al.  (1998) Methylenetetrahydrofolate reductase C677T mutation, plasma homocysteine, and folate in subjects from northern Italy with or without angiographically documented severe coronary atherosclerotic disease: evidence for an important genetic-environmental interaction. Blood  91: 4158–63.  <ul class="find" data-citedArticleID="919618"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Methylenetetrahydrofolate+reductase+C677T+mutation%2C+plasma+homocysteine%2C+and+folate+in+subjects+from+northern+Italy+with+or+without+angiographically+documented+severe+coronary+atherosclerotic+disease%3A+evidence+for+an+important+genetic-environmental+interaction.&amp;auth=&amp;atitle=Methylenetetrahydrofolate+reductase+C677T+mutation%2C+plasma+homocysteine%2C+and+folate+in+subjects+from+northern+Italy+with+or+without+angiographically+documented+severe+coronary+atherosclerotic+disease%3A+evidence+for+an+important+genetic-environmental+interaction." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Methylenetetrahydrofolate+reductase+C677T+mutation%2C+plasma+homocysteine%2C+and+folate+in+subjects+from+northern+Italy+with+or+without+angiographically+documented+severe+coronary+atherosclerotic+disease%3A+evidence+for+an+important+genetic-environmental+interaction." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Methylenetetrahydrofolate+reductase+C677T+mutation%2C+plasma+homocysteine%2C+and+folate+in+subjects+from+northern+Italy+with+or+without+angiographically+documented+severe+coronary+atherosclerotic+disease%3A+evidence+for+an+important+genetic-environmental+interaction.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">14.
              </span><a name="pone.0000083-Friso1" id="pone.0000083-Friso1"></a>Friso S, Girelli D, Martinelli N, Olivieri O, Lotto V, et al.  (2004) Low plasma vitamin B-6 concentrations and modulation of coronary artery disease risk. Am J Clin Nutr  79: 992–8.  <ul class="find" data-citedArticleID="919612"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Low+plasma+vitamin+B-6+concentrations+and+modulation+of+coronary+artery+disease+risk.&amp;auth=&amp;atitle=Low+plasma+vitamin+B-6+concentrations+and+modulation+of+coronary+artery+disease+risk." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Low+plasma+vitamin+B-6+concentrations+and+modulation+of+coronary+artery+disease+risk." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Low+plasma+vitamin+B-6+concentrations+and+modulation+of+coronary+artery+disease+risk.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">15.
              </span><a name="pone.0000083-Araki1" id="pone.0000083-Araki1"></a>Araki A, Sako Y (1987) Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr  422: 43–52.  <ul class="find" data-citedArticleID="919598" data-doi="10.1016/0378-4347(87)80438-3"><li><a href="http://dx.doi.org/10.1016/0378-4347(87)80438-3" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Determination+of+free+and+total+homocysteine+in+human+plasma+by+high-performance+liquid+chromatography+with+fluorescence+detection." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Determination+of+free+and+total+homocysteine+in+human+plasma+by+high-performance+liquid+chromatography+with+fluorescence+detection.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">16.
              </span><a name="pone.0000083-Nygard1" id="pone.0000083-Nygard1"></a>Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, et al.  (1997) Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med  337: 230–6.  <ul class="find" data-citedArticleID="919638" data-doi="10.1056/nejm199707243370403"><li><a href="http://dx.doi.org/10.1056/nejm199707243370403" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Plasma+homocysteine+levels+and+mortality+in+patients+with+coronary+artery+disease." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Plasma+homocysteine+levels+and+mortality+in+patients+with+coronary+artery+disease.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">17.
              </span><a name="pone.0000083-Anderson1" id="pone.0000083-Anderson1"></a>Anderson JL, Muhlestein JB, Horne BD, Carlquist JF, Bair TL, et al.  (2000) Plasma homocysteine predicts mortality independently of traditional risk factors and C-reactive protein in patients with angiographically defined coronary artery disease. Circulation  102: 1227–32.  <ul class="find" data-citedArticleID="919596" data-doi="10.1161/01.cir.102.11.1227"><li><a href="http://dx.doi.org/10.1161/01.cir.102.11.1227" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Plasma+homocysteine+predicts+mortality+independently+of+traditional+risk+factors+and+C-reactive+protein+in+patients+with+angiographically+defined+coronary+artery+disease." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Plasma+homocysteine+predicts+mortality+independently+of+traditional+risk+factors+and+C-reactive+protein+in+patients+with+angiographically+defined+coronary+artery+disease.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">18.
              </span><a name="pone.0000083-vanderGriend1" id="pone.0000083-vanderGriend1"></a>van der Griend R, Haas FJ, Duran M, Biesma DH, Meuwissen OJ, et al.  (1998) Methionine loading test is necessary for detection of hyperhomocysteinemia. J Lab Clin Med  132: 67–72.  <ul class="find" data-citedArticleID="919654" data-doi="10.1016/s0022-2143(98)90027-0"><li><a href="http://dx.doi.org/10.1016/s0022-2143(98)90027-0" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Methionine+loading+test+is+necessary+for+detection+of+hyperhomocysteinemia." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Methionine+loading+test+is+necessary+for+detection+of+hyperhomocysteinemia.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">19.
              </span><a name="pone.0000083-Graham1" id="pone.0000083-Graham1"></a>Graham IM, Daly LE, Refsum HM, Robinson K, Brattstrom LE, et al.  (1997) Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA  277: 1775–81.  <ul class="find" data-citedArticleID="919620" data-doi="10.1001/jama.1997.03540460039030"><li><a href="http://dx.doi.org/10.1001/jama.1997.03540460039030" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Plasma+homocysteine+as+a+risk+factor+for+vascular+disease.+The+European+Concerted+Action+Project." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Plasma+homocysteine+as+a+risk+factor+for+vascular+disease.+The+European+Concerted+Action+Project.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">20.
              </span><a name="pone.0000083-Refsum2" id="pone.0000083-Refsum2"></a>Refsum H, Smith AD, Ueland PM, Nexo E, Clarke R, et al.  (2004) McPartlin J, Johnston C, Engbaek F, Schneede J, McPartlin C, Scott JM. Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem  50: 3–32.  <ul class="find" data-citedArticleID="919642"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=McPartlin+J%2C+Johnston+C%2C+Engbaek+F%2C+Schneede+J%2C+McPartlin+C%2C+Scott+JM.+Facts+and+recommendations+about+total+homocysteine+determinations%3A+an+expert+opinion.&amp;auth=&amp;atitle=McPartlin+J%2C+Johnston+C%2C+Engbaek+F%2C+Schneede+J%2C+McPartlin+C%2C+Scott+JM.+Facts+and+recommendations+about+total+homocysteine+determinations%3A+an+expert+opinion." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=McPartlin+J%2C+Johnston+C%2C+Engbaek+F%2C+Schneede+J%2C+McPartlin+C%2C+Scott+JM.+Facts+and+recommendations+about+total+homocysteine+determinations%3A+an+expert+opinion." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22McPartlin+J%2C+Johnston+C%2C+Engbaek+F%2C+Schneede+J%2C+McPartlin+C%2C+Scott+JM.+Facts+and+recommendations+about+total+homocysteine+determinations%3A+an+expert+opinion.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">21.
              </span><a name="pone.0000083-Brattstrm1" id="pone.0000083-Brattstrm1"></a>Brattström L, Wilcken DE, Ohrvik J, Brudin L (1998) Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a metaanalysis. Circulation  98: 2520–6.  <ul class="find" data-citedArticleID="919602" data-doi="10.1161/01.cir.98.23.2520"><li><a href="http://dx.doi.org/10.1161/01.cir.98.23.2520" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Common+methylenetetrahydrofolate+reductase+gene+mutation+leads+to+hyperhomocysteinemia+but+not+to+vascular+disease%3A+the+result+of+a+metaanalysis." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Common+methylenetetrahydrofolate+reductase+gene+mutation+leads+to+hyperhomocysteinemia+but+not+to+vascular+disease%3A+the+result+of+a+metaanalysis.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">22.
              </span><a name="pone.0000083-DaveySmith1" id="pone.0000083-DaveySmith1"></a>Davey Smith G, Ebrahim S (2003) “Mendelian randomization”: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol  32: 1–22.  <ul class="find" data-citedArticleID="919604" data-doi="10.1093/ije/dyg070"><li><a href="http://dx.doi.org/10.1093/ije/dyg070" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=%26%23x201c%3BMendelian+randomization%26%23x201d%3B%3A+can+genetic+epidemiology+contribute+to+understanding+environmental+determinants+of+disease%3F" target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22%26%23x201c%3BMendelian+randomization%26%23x201d%3B%3A+can+genetic+epidemiology+contribute+to+understanding+environmental+determinants+of+disease%3F%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">23.
              </span><a name="pone.0000083-Frederiksen1" id="pone.0000083-Frederiksen1"></a>Frederiksen J, Juul K, Grande P, Jensen GB, Schroeder TV, et al.  (2004) Methylenetetrahydrofolate reductase polymorphism (C677T), hyperhomocysteinemia, and risk of ischemic cardiovascular disease and venous thromboembolism: prospective and case-control studies from the Copenhagen City Heart Study. Blood  104: 3046–51.  <ul class="find" data-citedArticleID="919610" data-doi="10.1182/blood-2004-03-0897"><li><a href="http://dx.doi.org/10.1182/blood-2004-03-0897" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Methylenetetrahydrofolate+reductase+polymorphism+%28C677T%29%2C+hyperhomocysteinemia%2C+and+risk+of+ischemic+cardiovascular+disease+and+venous+thromboembolism%3A+prospective+and+case-control+studies+from+the+Copenhagen+City+Heart+Study." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Methylenetetrahydrofolate+reductase+polymorphism+%28C677T%29%2C+hyperhomocysteinemia%2C+and+risk+of+ischemic+cardiovascular+disease+and+venous+thromboembolism%3A+prospective+and+case-control+studies+from+the+Copenhagen+City+Heart+Study.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">24.
              </span><a name="pone.0000083-Eagle1" id="pone.0000083-Eagle1"></a>Eagle KA, Guyton RA, Davidoff R, Ewy GA, Fonger J, et al.  (1999) ACC/AHA guidelines for coronary artery bypass graft surgery: executive summary and recommendations : A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1991 guidelines for coronary artery bypass graft surgery). Circulation  100: 1464–80.  <ul class="find" data-citedArticleID="919606" data-doi="10.1161/01.cir.100.13.1464"><li><a href="http://dx.doi.org/10.1161/01.cir.100.13.1464" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=ACC%2FAHA+guidelines+for+coronary+artery+bypass+graft+surgery%3A+executive+summary+and+recommendations+%3A+A+report+of+the+American+College+of+Cardiology%2FAmerican+Heart+Association+Task+Force+on+Practice+Guidelines+%28Committee+to+revise+the+1991+guidelines+for+coronary+artery+bypass+graft+surgery%29." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22ACC%2FAHA+guidelines+for+coronary+artery+bypass+graft+surgery%3A+executive+summary+and+recommendations+%3A+A+report+of+the+American+College+of+Cardiology%2FAmerican+Heart+Association+Task+Force+on+Practice+Guidelines+%28Committee+to+revise+the+1991+guidelines+for+coronary+artery+bypass+graft+surgery%29.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">25.
              </span><a name="pone.0000083-The1" id="pone.0000083-The1"></a>The Post Coronary Artery Bypass Graft Trial Investigators (1997) The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts. N Engl J Med  336: 153–62.  <ul class="find" data-citedArticleID="919648" data-doi="10.1056/nejm199701163360301"><li><a href="http://dx.doi.org/10.1056/nejm199701163360301" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=The+effect+of+aggressive+lowering+of+low-density+lipoprotein+cholesterol+levels+and+low-dose+anticoagulation+on+obstructive+changes+in+saphenous-vein+coronary-artery+bypass+grafts." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22The+effect+of+aggressive+lowering+of+low-density+lipoprotein+cholesterol+levels+and+low-dose+anticoagulation+on+obstructive+changes+in+saphenous-vein+coronary-artery+bypass+grafts.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">26.
              </span><a name="pone.0000083-Ridker1" id="pone.0000083-Ridker1"></a>Ridker PM, Cannon CP, Morrow D, Rifai N, Rose LM, et al.  (2005) Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) Investigators. C-reactive protein levels and outcomes after statin therapy. N Engl J Med  352: 20–8.  <ul class="find" data-citedArticleID="919644" data-doi="10.1517/14656566.6.9.1597"><li><a href="http://dx.doi.org/10.1517/14656566.6.9.1597" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Pravastatin+or+Atorvastatin+Evaluation+and+Infection+Therapy-Thrombolysis+in+Myocardial+Infarction+22+%28PROVE+IT-TIMI+22%29+Investigators.+C-reactive+protein+levels+and+outcomes+after+statin+therapy." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Pravastatin+or+Atorvastatin+Evaluation+and+Infection+Therapy-Thrombolysis+in+Myocardial+Infarction+22+%28PROVE+IT-TIMI+22%29+Investigators.+C-reactive+protein+levels+and+outcomes+after+statin+therapy.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">27.
              </span><a name="pone.0000083-Smulders1" id="pone.0000083-Smulders1"></a>Smulders YM, Stehouwer CD (2005) Folate metabolism and cardiovascular disease. Semin Vasc Med  5: 87–97.  <ul class="find" data-citedArticleID="919646" data-doi="10.1055/s-2005-872395"><li><a href="http://dx.doi.org/10.1055/s-2005-872395" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Folate+metabolism+and+cardiovascular+disease." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Folate+metabolism+and+cardiovascular+disease.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">28.
              </span><a name="pone.0000083-Friso2" id="pone.0000083-Friso2"></a>Friso S, Choi SW, Girelli D, Mason JB, Dolnikowski GG, et al.  (2002) A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc Natl Acad Sci U S A  99: 5606–11.  <ul class="find" data-citedArticleID="919614" data-doi="10.1073/pnas.062066299"><li><a href="http://dx.doi.org/10.1073/pnas.062066299" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=A+common+mutation+in+the+5%2C10-methylenetetrahydrofolate+reductase+gene+affects+genomic+DNA+methylation+through+an+interaction+with+folate+status." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22A+common+mutation+in+the+5%2C10-methylenetetrahydrofolate+reductase+gene+affects+genomic+DNA+methylation+through+an+interaction+with+folate+status.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">29.
              </span><a name="pone.0000083-Loscalzo1" id="pone.0000083-Loscalzo1"></a>Loscalzo J (2006) Homocysteine trials--clear outcomes for complex reasons. N Engl J Med  354: 1629–32.  <ul class="find" data-citedArticleID="919634" data-doi="10.1056/nejme068060"><li><a href="http://dx.doi.org/10.1056/nejme068060" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Homocysteine+trials--clear+outcomes+for+complex+reasons." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Homocysteine+trials--clear+outcomes+for+complex+reasons.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">30.
              </span><a name="pone.0000083-Jacques1" id="pone.0000083-Jacques1"></a>Jacques PF, Selhub J, Bostom AG, Wilson PW, Rosenberg IH (1999) The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med  340: 1449–54.  <ul class="find" data-citedArticleID="919624" data-doi="10.1056/nejm199905133401901"><li><a href="http://dx.doi.org/10.1056/nejm199905133401901" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=The+effect+of+folic+acid+fortification+on+plasma+folate+and+total+homocysteine+concentrations." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22The+effect+of+folic+acid+fortification+on+plasma+folate+and+total+homocysteine+concentrations.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li></ol></div>

  </div>

      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000083.XML" value="122835"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000083.PDF" value="244024"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000083.t001.PNG_L" value="353766"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000083.t001.PNG_M" value="40278"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000083.t001.PNG_S" value="3368"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000083.t001.TIF" value="19401858"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000083.t001.PNG_I" value="20930"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000083.t002.PNG_L" value="55003"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000083.t002.PNG_M" value="23243"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000083.t002.PNG_S" value="2123"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000083.t002.TIF" value="2284010"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000083.t002.PNG_I" value="10262"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000083.g001.PNG_L" value="1503101"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000083.g001.PNG_M" value="172403"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000083.g001.PNG_S" value="5097"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000083.g001.TIF" value="2271268"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000083.g001.PNG_I" value="71359"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000083.t003.PNG_L" value="222535"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000083.t003.PNG_M" value="36310"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000083.t003.PNG_S" value="2343"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000083.t003.TIF" value="7124778"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000083.t003.PNG_I" value="15270"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000083.t004.PNG_L" value="79865"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000083.t004.PNG_M" value="35743"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000083.t004.PNG_S" value="2476"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000083.t004.TIF" value="2138420"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000083.t004.PNG_I" value="15692"/>

</div>
<div class="sidebar">

  <div class="article-actions cf">
      <div class="download">
        <span class="btn"><a href="/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0000083&amp;representation=PDF" title="Download" target="_blank">Download PDF</a></span>
      </div>
      <div class="btn-reveal dropdown">
        <div class="dropdown-icon">
          <span class="btn">&nbsp;</span>
        </div>

        <div class="content">
          <ul class="bullet">
            <li><a href="/article/citationList.action?articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0000083" title="Download citations">Citation</a></li>
            <li><a href="/article/fetchObjectAttachment.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0000083&amp;representation=XML" title="Download article XML">XML</a></li>
          </ul>
        </div>
      </div> <!-- end btn-reveal dropdown-->


    <div class="btn-reveal flt-l">
        <span class="btn">Print</span>
        <div class="content">
            <ul class="bullet">
                <li id="print-article"><a href="#" onclick="if(typeof(_gaq) != 'undefined'){ _gaq.push(['_trackEvent','Article', 'Print', 'Click']); } window.print(); return false;" title="Print Article">Print article</a></li>
                <li>
                  <a href="https://www.odysseypress.com/onlinehost/reprint_order.php?type=A&page=0&journal=7&doi=10.1371/journal.pone.0000083&volume=&issue=&title=Hyperhomocysteinemia and Mortality after Coronary Artery Bypass Grafting&author_name=Domenico%20Girelli%2C%20Nicola%20Martinelli%2C%20Oliviero%20Olivieri%2C%20Francesca%20Pizzolo%2C%20Simonetta%20Friso%2C%20Giovanni%20Faccini%2C%20Claudia%20Bozzini%2C%20Ilaria%20Tenuti%2C%20Valentina%20Lotto%2C%20Giuliano%20Villa%2C%20Patrizia%20Guarini%2C%20Elisabetta%20Trabetti%2C%20Pier%20Franco%20Pignatti%2C%20Alessandro%20Mazzucco%2C%20Roberto%20Corrocher&start_page=1&end_page=7" title="Odyssey Press">EzReprint</a>
                </li>
            </ul>
        </div>
    </div>

    <div class="btn-reveal flt-r">
        <span class="btn">Share</span>
        <div class="content">
            <ul class="social">
                <li><a href="http://www.reddit.com/submit?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000083" target="_blank" title="Submit to Reddit"><img src="/images/icon.reddit.16.png" width="16" height="16" alt="Reddit">Reddit</a></li>

                <li><a href="https://plus.google.com/share?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000083" target="_blank" title="Share on Google+"><img src="/images/icon.gplus.16.png" width="16" height="16" alt="Google+">Google+</a></li>

                <li><a href="http://www.stumbleupon.com/submit?url=http%3A%2F%2Fwww.plosone.org%2Farticle%2Finfo%253Adoi%252F10.1371%252Fjournal.pone.0000083" target="_blank" title="Add to StumbleUpon"><img src="/images/icon.stumble.16.png" width="16" height="16" alt="StumbleUpon">StumbleUpon</a></li>

                <li><a href="http://www.facebook.com/share.php?u=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000083&amp;t=Hyperhomocysteinemia%20and%20Mortality%20after%20Coronary%20Artery%20Bypass%20Grafting" target="_blank" title="Share on Facebook"><img src="/images/icon.fb.16.png" width="16" height="16" alt="Facebook">Facebook</a></li>

                <li><a href="http://www.linkedin.com/shareArticle?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000083&title=Hyperhomocysteinemia%20and%20Mortality%20after%20Coronary%20Artery%20Bypass%20Grafting&summary=Checkout%20this%20article%20I%20found%20at%20PLOS" target="_blank" title="Add to LinkedIn"><img src="/images/icon.linkedin.16.png" width="16" height="16" alt="Mendeley">LinkedIn</a></li>

                <li><a href="http://www.citeulike.org/posturl?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000083&amp;title=Hyperhomocysteinemia%20and%20Mortality%20after%20Coronary%20Artery%20Bypass%20Grafting" target="_blank" title="Add to CiteULike"><img src="/images/icon.cul.16.png" width="16" height="16" alt="CiteULike">CiteULike</a></li>

                <li><a href="http://www.mendeley.com/import/?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000083" target="_blank" title="Add to Mendeley"><img src="/images/icon.mendeley.16.png" width="16" height="16" alt="Mendeley">Mendeley</a></li>

                <li><a href="https://www.pubchase.com/library?add_aid=10.1371%2Fjournal.pone.0000083&amp;source=plos" target="_blank" title="Add to PubChase"><img src="/images/icon.pc.16.png" width="16" height="16" alt="PubChase">PubChase</a></li>


                <script type="text/javascript">
                    // replace tweet with one that's pre-shortened to 140 chars
                    function truncateTweetText() {
                        var twtTitle = 'Hyperhomocysteinemia and Mortality after Coronary Artery Bypass Grafting';
                        var twtUrl = 'http://dx.plos.org/10.1371/journal.pone.0000083';
                        // all URLs posted to twitter get auto-shortened to 20 chars.
                        var maxLength = 140 - (20 + 1);
                        // truncate the title to include space for twtTag and ellipsis (here, 10 = tag length + space + ellipsis)
                        if (twtTitle.length > maxLength) { twtTitle = twtTitle.substr(0, (maxLength - 10)) + '...'; }
                        // set the href to use the shortened tweet
                        $('#twitter-share-link').prop('href', 'http://twitter.com/intent/tweet?text=' + encodeURIComponent('#PLOSONE: ' + twtTitle + ' ' + twtUrl));
                    }
                </script>
                <li><a href="http://twitter.com/intent/tweet?text=#PLOSONE%3A%20Hyperhomocysteinemia%20and%20Mortality%20after%20Coronary%20Artery%20Bypass%20Grafting http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000083" onclick="truncateTweetText();" target="_blank" title="Share on Twitter" id="twitter-share-link"><img src="/images/icon.twtr.16.png" width="16" height="16" alt="Twitter">Twitter</a></li>

                <li><a href="/article/email/info%3Adoi%2F10.1371%2Fjournal.pone.0000083" title="Email this article"><img src="/images/icon.email.16.png" width="16" height="16" alt="Email">Email</a></li>
            </ul>
        </div>
    </div><!--end btn-reveal flt-r-->
</div><!-- end article-actions-->

<!-- begin Crossmark -->

<a id="open-crossmark" href="#" style="margin-top: -28px; display:block"><img style="border: 0; display: none;
 padding: 10px 0 18px 0;"  id="crossmark-icon" src="/images/logo-crossmark-bw.png" /></a>
<div id="crossmark-dialog" style="display: none;" title="">
    <!-- the external CrossMark data is loaded inside this iframe -->
    <iframe id="crossmark-dialog-frame" frameborder="0"></iframe>
</div>

<!-- end crossmark -->


<div class="block" id="subject-area-sidebar-block">
    <div class="header">
        <h3>Subject Areas</h3><div title="More information" id="subject-area-sidebar-block-help-icon"><img align="right"
                                                                                                           alt="info" src="/images/button_info.png"/><div id="subject-area-sidebar-block-help"><img align="right"
                                                                                                                                                                                                    src="/images/button_info.png"/><p>
        <b>We want your feedback.</b> Do these subject areas make sense for this article? If not, click the flag
        next to the incorrect subject area and we will review it. Thanks for your help!
    </p></div></div>
    </div>


    <ul id="subject-area-sidebar-list">











          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Cardiovascular+therapy%22" title="Search for articles in the subject area:'Cardiovascular therapy'"><div class="flagText">Cardiovascular therapy</div></a>
              <div data-categoryid="26035" data-articleid="23006"
                   data-categoryname="Cardiovascular therapy"
                   class="flagImage" title="Flag 'Cardiovascular therapy' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Cobalamins%22" title="Search for articles in the subject area:'Cobalamins'"><div class="flagText">Cobalamins</div></a>
              <div data-categoryid="43631" data-articleid="23006"
                   data-categoryname="Cobalamins"
                   class="flagImage" title="Flag 'Cobalamins' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Coronary+artery+bypass+grafting%22" title="Search for articles in the subject area:'Coronary artery bypass grafting'"><div class="flagText">Coronary artery bypass grafting</div></a>
              <div data-categoryid="24773" data-articleid="23006"
                   data-categoryname="Coronary artery bypass grafting"
                   class="flagImage" title="Flag 'Coronary artery bypass grafting' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Coronary+artery+disease%22" title="Search for articles in the subject area:'Coronary artery disease'"><div class="flagText">Coronary artery disease</div></a>
              <div data-categoryid="22683" data-articleid="23006"
                   data-categoryname="Coronary artery disease"
                   class="flagImage" title="Flag 'Coronary artery disease' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Death+rates%22" title="Search for articles in the subject area:'Death rates'"><div class="flagText">Death rates</div></a>
              <div data-categoryid="51935" data-articleid="23006"
                   data-categoryname="Death rates"
                   class="flagImage" title="Flag 'Death rates' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Drug+therapy%22" title="Search for articles in the subject area:'Drug therapy'"><div class="flagText">Drug therapy</div></a>
              <div data-categoryid="18461" data-articleid="23006"
                   data-categoryname="Drug therapy"
                   class="flagImage" title="Flag 'Drug therapy' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Prospective+studies%22" title="Search for articles in the subject area:'Prospective studies'"><div class="flagText">Prospective studies</div></a>
              <div data-categoryid="25769" data-articleid="23006"
                   data-categoryname="Prospective studies"
                   class="flagImage" title="Flag 'Prospective studies' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Vitamins%22" title="Search for articles in the subject area:'Vitamins'"><div class="flagText">Vitamins</div></a>
              <div data-categoryid="43801" data-articleid="23006"
                   data-categoryname="Vitamins"
                   class="flagImage" title="Flag 'Vitamins' as inappropriate"></div>
          </li>
    </ul>
</div>

<div class="ad">
    <div class="title">Advertisement</div>






  <iframe id='a0852f54' name='a0852f54'
    src='http://ads.plos.org/www/delivery/afr.php?zoneid=381&amp;cb=1322'
    frameborder='0' scrolling='no' width='160' height='600'>
    <a href='http://ads.plos.org/www/delivery/ck.php?n=a0852f54&amp;cb=8276'
      target='_top'><img src='http://ads.plos.org/www/delivery/avw.php?zoneid=381&amp;cb=9669&amp;n=a0852f54'
      border='0' alt=''/>
    </a>
  </iframe>



</div>

<div id="twitter-alm-timeline" class="twitter-alm-timeline"></div>


</div><!-- sidebar -->
    </div>
  </div>
</div>
<script src="http://wl.figshare.com/static/p_widget.js" type="text/javascript"></script><div id="pageftr">
  <div class="ftr-cols cf">
    <div class="col col-1">
      <img src="/images/logo-plos-footer.png" alt="PLOS Logo" class="logo" />
      <p><a href="/static/releaseNotes">Ambra 2.9.16</a> Managed Colocation provided <br />by <a href="http://www.isc.org/">Internet Systems Consortium</a>.<p>
      <div class="nav nav-aux">
        <a href="/static/privacy">Privacy Policy</a> |
        <a href="/static/terms">Terms of Use</a> |
        <a href="http://www.plos.org/advertise/">Advertise</a> |
        <a href="http://www.plos.org/about/media-inquiries/">Media Inquiries</a>
      </div>
    </div>
    <div class="col col-2">
      <p><a href="http://www.plos.org/publications/journals/">Publications</a></p>
      <div class="nav">
        <ul>
          <li><a href="http://www.plosbiology.org">PLOS Biology</a></li>
          <li><a href="http://www.plosmedicine.org">PLOS Medicine</a></li>
          <li><a href="http://www.ploscompbiol.org">PLOS Computational Biology</a></li>
          <li><a href="http://currents.plos.org">PLOS Currents</a></li>
          <li><a href="http://www.plosgenetics.org">PLOS Genetics</a></li>
          <li><a href="http://www.plospathogens.org">PLOS Pathogens</a></li>
          <li><a href="http://www.plosone.org">PLOS ONE</a></li>
          <li><a href="http://www.plosntds.org">PLOS Neglected Tropical Diseases</a></li>
        </ul>
      </div>
    </div>
    <div class="col col-3">
      <div class="nav">
        <p><a href="http://www.plos.org">plos.org</a></p>
        <p><a href="http://blogs.plos.org">Blogs</a></p>
        <p><a href="http://www.ploscollections.org">Collections</a></p>
        <p><a href="/feedback/new">Send us feedback</a></p>

        <p>California (US) corporation #C2354500, based in San Francisco</p>
      </div>
    </div>
  </div>
</div><!-- pageftr -->

</div><!-- end page-wrap, this div is in header.ftl -->
<script type="text/javascript" src="/javascript/jquery-1.8.1-min.js?v=Tm7VCOzZz3lE03ghpkS6SWkHbyI"></script>
<script type="text/javascript" src="/javascript/ga-min.js?v=lNQ4gt8QcPDatjsdOFl_FGpPhLY"></script>
<script type="text/javascript" src="/javascript/jquery.hoverIntent-min.js?v=mRiGNYY9cIXxVb8u0K_MdW7hHnc"></script>
<script type="text/javascript" src="/javascript/jquery.placeholder-min.js?v=21Pn56Ur9h1N4K4VZDa0nqI3Pxo"></script>
<script type="text/javascript" src="/javascript/jquery.jsonp-2.4.0-min.js?v=lqTpzoHfSq3I5Ygo01qq5WankEo"></script>
<script type="text/javascript" src="/javascript/jquery-ui-1.9.2.custom-min.js?v=raSSlfNO0YsV5uUpAKmTB9n5VTc"></script>
<script type="text/javascript" src="/javascript/jquery.tooltip-min.js?v=cw+6Smh+mdryIA25xvqIvHMrnZM"></script>
<script type="text/javascript" src="/javascript/jquery.uniform-min.js?v=kYUAnX6W2W_2fK3RIuQ2m_YFG9U"></script>
<script type="text/javascript" src="/javascript/jquery.pjax-min.js?v=939kLBjL5_YKbx71T1RHjYaD4l8"></script>
<script type="text/javascript" src="/javascript/imagesloaded-min.js?v=XeuAp8Gc3mvQUo+wZCSF8ttPwvw"></script>
<script type="text/javascript" src="/javascript/figviewer-min.js?v=yPUa0sUQ_iHkI+IRv2i9bjyZJFo"></script>
<script type="text/javascript" src="/javascript/global-min.js?v=0Q3PwjeaWtXYDnqIsQvnL_ou0qs"></script>
<script type="text/javascript" src="/javascript/jquery.touchswipe-min.js?v=huaek_e6HqTduvCNAN91dJolTyw"></script>
<script type="text/javascript" src="/javascript/jquery.base64-min.js?v=VwV1zeVqKZj5FCAdlK0q5NRxbBg"></script>
<script type="text/javascript" src="/javascript/alm-min.js?v=Y5gm6B0b4Kx2YHNObNrgEeBgXlY"></script>
<script type="text/javascript" src="/javascript/taxonomy-browser-min.js?v=vBVMuDMYkGJCXIUxLe35GoyiJNw"></script>
<script type="text/javascript" src="/javascript/jquery.filterize-min.js?v=j0ZKVnHyk2nhFy8eIuNJkp7xaM0"></script>
<script type="text/javascript" src="/javascript/plosone-min.js?v=TK4H4arL_XBSwwJq+K1N3kqYfAI"></script>
<script type="text/javascript" src="/javascript/twitter-min.js?v=xKgcxLsQFXy+at1ao1NVke8nFlM"></script>
<script type="text/javascript" src="/javascript/crossmark.1.4-min.js?v=3FO4k0SjwTaGNnKGNSqthar1080"></script>
<script type="text/javascript">
  var _sf_async_config={uid:16579,domain:"plosone.org"};
  (function(){
    function loadChartbeat() {
      window._sf_endpt=(new Date()).getTime();
      var e = document.createElement('script');
      e.setAttribute('language', 'javascript');
      e.setAttribute('type', 'text/javascript');
      e.setAttribute('src',
          (("https:" == document.location.protocol) ? "https://a248.e.akamai.net/chartbeat.download.akamai.com/102508/" : "http://static.chartbeat.com/") +
              "js/chartbeat.js");
      document.body.appendChild(e);
    }
    var oldonload = window.onload;
    window.onload = (typeof window.onload != 'function') ?
        loadChartbeat : function() { oldonload(); loadChartbeat(); };
  })();
</script>
<!-- <script type="application/javascript" src="http://crossmark.crossref.org/javascripts/v1.3/crossmark.min.js"></script> -->

</body>
</html>
